Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division
  • Business Sort ascending
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Site Standort Division Business Sort ascending Functional Area Erscheinungsdatum
Sr. Spec. DDIT IES Database Services INSURGENTES Mexiko Operations CTS Technology Transformation Aug 27, 2024
Snr. Specialist MDM (Master Data Management - implementation using Reltio) Hyderabad (Office) Indien Operations CTS Technology Transformation Aug 28, 2024
Snr Specialist(Power BI & Embedded Analytics - Web applications) Hyderabad (Office) Indien Operations CTS Technology Transformation Aug 28, 2024
Assoc. Dir Content Engineering(Azure -AWS-Application management Documentum) Hyderabad (Office) Indien Operations CTS Technology Transformation Sep 03, 2024
Associate Director - Technology Modernization(Application Portfolio Management, Project/Program Management) Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 18, 2024
IT Senior Project Manager Barcelona Gran Vía Spanien Operations CTS Technology Transformation Okt 18, 2024
Director of Global & Swiss Media & Editorial Basel (City) Schweiz Corporate CTS Communications & Public Affairs Okt 18, 2024
Sr. Spec. DDIT ISC Gov GxP Assessments Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 18, 2024
Sr. Spec. DDIT IES Supplier Management Hyderabad (Office) Indien Operations CTS Informationstechnologie Okt 18, 2024
Record to Report (R2R) Specialist New Cairo Ägypten Finance CTS Audit und Finanzen Okt 18, 2024
Record to Report (R2R) Section Head New Cairo Ägypten Finance CTS Audit und Finanzen Okt 18, 2024
Sr. Spec. Solution Delivery HCM Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 18, 2024
Manager, Analytical Product Services Hyderabad (Office) Indien Operations CTS Marketing Okt 17, 2024
IT Business Partner Director for Clinical Development Barcelona Gran Vía Spanien Operations CTS Technology Transformation Okt 17, 2024
Manager, Analytical Product Services Hyderabad (Office) Indien Operations CTS Marketing Okt 17, 2024
Lead Consultant – M&A Post-merger Integrations | Separations Prague Tschechische Republik Operations CTS BD&L & Strategic Planning Okt 09, 2024
Data Steward Hyderabad (Office) Indien Operations CTS Marketing Okt 09, 2024
LDC PMO Resource Specialist Prague Tschechische Republik Operations CTS Technology Transformation Okt 09, 2024
Sr. Specialist DDIT ISC Cyber Solutions Engineering Prague Tschechische Republik Operations CTS Technology Transformation Okt 09, 2024
Associate Director, Enterprise Architect Network Security Barcelona Gran Vía Spanien Operations CTS Technology Transformation Okt 16, 2024
Human Resources Services Expert with German Prague Tschechische Republik People & Organization CTS Humanressourcen Okt 16, 2024
Comms & Engagement Manager Amsterdam Niederlande Corporate Affairs CTS Communications & Public Affairs Okt 16, 2024
Executive Director, Therapy Area Communications and Patient Advocacy Basel (City) Schweiz Corporate Affairs CTS Communications & Public Affairs Okt 16, 2024
H2R Services Expert Moscow (City) Russische Foed. People & Organization CTS Humanressourcen Okt 16, 2024
Manager - FC&C Hyderabad (Office) Indien Finance CTS Audit und Finanzen Okt 16, 2024
Sr. Spec. DDIT IES NW Engg Hyderabad (Office) Indien Operations CTS Technology Transformation Okt 16, 2024
Senior Analyst Commercial Analytics Hyderabad (Office) Indien Operations CTS Marketing Okt 16, 2024
Analyst - SFE Products Hyderabad (Office) Indien Operations CTS Marketing Mai 20, 2024
Senior Specialist DDIT OPS Mfg Site IT Sasayama Japan Operations CTS Informationstechnologie Jul 22, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit und Finanzen Okt 06, 2024
R2R Accountant Moscow (City) Russische Foed. Finance CTS Audit und Finanzen Jul 25, 2024
Analyst - SFE Products Hyderabad (Office) Indien Operations CTS Marketing Mai 20, 2024
Analyst - SFE Products Hyderabad (Office) Indien Operations CTS Marketing Mai 20, 2024
Analyst - SFE Products Hyderabad (Office) Indien Operations CTS Marketing Mai 20, 2024
Revenue Accounting Manager Shanghai (Shanghai) China Finance CTS Audit und Finanzen Jul 17, 2024
Associate Director, SUSE Linux Administrator Prague Tschechische Republik Operations Corporate Technology Transformation Sep 23, 2024
Juristisches Volontariat – Novartis Corporate Functions Basel (City) Schweiz Legal Corporate Others Sep 26, 2024
Senior Accountant, Tax Shanghai (Shanghai) China Finance Corporate Audit und Finanzen Aug 29, 2024
Global Digital FRA Automation Lead Hyderabad (Office) Indien Finance Corporate Audit und Finanzen Jun 20, 2024
Corporate Tax Manager Amiria Ägypten Finance Corporate Audit und Finanzen Mai 31, 2024
Financial Analyst - SoD Ops Hyderabad (Office) Indien Finance Corporate Audit und Finanzen Sep 17, 2024
Associate Director, Data Privacy, Digital & AI East Hanover USA Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compliance Sep 04, 2024
Associate Director, US Federal and State Tax Reporting East Hanover USA Finance Corporate Audit und Finanzen Sep 06, 2024
Expert Analyst – Management Reporting Prague Tschechische Republik Finance Corporate Audit und Finanzen Okt 08, 2024
Senior Product Manager, Digital Finance Barcelona Gran Vía Spanien Finance Corporate Audit und Finanzen Okt 01, 2024
Tax Manager m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Deutschland Finance Corporate Audit und Finanzen Okt 16, 2024
Associate Director ERC Risk&Operations, Corporate Functions Selangor Malaysia Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compliance Aug 29, 2024
Manager- Data Privacy Review and Remediation Telangana Indien Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compliance Okt 10, 2024
Manager- Data Privacy Review and Remediation Selangor Malaysia Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compliance Okt 14, 2024
BPA Manager - Global Process Owner Hyderabad (Office) Indien Finance Corporate Audit und Finanzen Okt 15, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.